The global demand for Glutethimide Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Glutethimide is a hypnotic sedative that can be used instead of barbiturates to treat insomnia. It is primarily used to make patients sleepy and quiet. Glutathimide is a lipophilic compound that accumulates in adipose tissue and the brain. It's a non-addictive alternative to barbiturates. It is extensively metabolised in the liver, producing both unconjugated and conjugated metabolites, which are excreted via the kidney. When combined with codeine, glutethimide acts as a CYP2D6 enzyme inducer, allowing the body to convert a large amount of codeine to morphine. Ciba, glue, and gofers are the most frequent brand names for glutethimide. It is classified as a psychotropic substance and is classified as a category II drug. Furthermore, glutethimide is utilised to prevent infant jaundice and to minimise muscle spasms.
Market Dynamics
Increase in cases of cardiovascular depression, rise in demand to maintain calmness and induce sleep, increase in cases of mental illness, rise in demand for treatment of psychiatric patient to reduce tension, rise in demand for the brands such as doriden, elrodorm, glimid, rise in development of new analgesic drugs, increase in availability of drugs such as butisol, ambien, restoril, zolpimist, and increase in seizure disorders are factors that drive the growth of glutethimide market. In addition, increase in healthcare expenditure; availability of skilled professionals; collaborations & partnerships between key players to facilitate drug development; rise in R&D activities to improve quality of drugs; launch of novel developed drug in market; and technological development such as computer technology, aseptic spray drying, 3 D printing to manufacture a drug which boost the market growth for glutethimide market. However, side effects associated with glutethimide and drug shortage hinder the market growth. Contrarily, increase in awareness regarding treatment of insomnia and government initiatives for regulatory approvals are few more factors expected to raise the market growth under the forecast period.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of glutethimide. The growth and trends of glutethimide industry provide a holistic approach to this study.
Market Segmentation
This section of the glutethimide market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Tablets
- Injection
- Capsules
- Powder
- Herbal Compounds
By Application
- Psychiatric Disorders
- Prostatic Hypertrophy
- Cardiac Arrhythmias
By Distribution Channel
- Hospital Pharmacy
- Drug Stores
- Retail Pharmacy
- Online Pharmacy
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Glutethimide market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Glutethimide Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the glutethimide market include Pfizer Inc., Abbott Laboratories, Mankind Pharma, Glaxosimithkine PLC, Sanofi S.A, Novartis, Agilent Technologies, Abbvie Inc, Bristol Mayers Squibb, Astrazeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
